Beauty Salon-Based Intervention Builds Knowledge of PrEP in Black Women
One challenge is that women perceive their risk for HIV infection as low.
HIV/AIDS Information Center
Risk for Major Depressive Disorder Increased Within First 2 Years of HIV Diagnosis
Researchers evaluated the risk for major depressive disorder among patients with HIV infection.
Single-Tablet Regimen Well Tolerated for HIV Post-Exposure Prophylaxis
Researchers evaluated adherence to nonoccupational post-exposure prophylaxis following potential HIV exposure.
HIV-Specific Variables Play Vital Role in Severe COVID-19 Outcomes
Researchers examined factors associated with COVID-19 infection and severe outcomes among patients with HIV infection.
Barriers of Implementing Long-Acting Injectable ART at HIV Clinics
Researchers assessed barriers associated with the implementation of long-acting injectable antiretroviral therapy at HIV clinics in the United States.
Data Support Dolutegravir Twice Daily With Rifampicin Induction for HIV With Obesity
Researchers assessed the effect of obesity on the drug-drug interaction between dolutegravir and rifampicin among individuals with HIV infection.
Switch to DTG/3TC Does Not Negatively Affect Cardiometabolic Health in HIV
Researchers evaluated cardiometabolic outcomes among patients with HIV infection 3 years who switched to dolutegravir/lamivudine-based antiretroviral therapy.
Chronic Pain Common Among Women With HIV Infection
Researchers evaluated the prevalence of chronic pain among women with HIV infection in a systematic review and meta-analysis.
USPSTF Reaffirms Recommendation of PrEP for Those at Increased HIV Risk
Considerable net benefit seen for use of effective antiretroviral therapy for reducing risk for HIV acquisition.
Enrollment in Medicare: Updates for People Living With HIV
The Association of Nurses in AIDS Care hosted a webinar where representatives from the Access, Care, and Engagement Technical Assistance Center discussed updates to Medicaer coverage for patients living with HIV.
Pitavastatin Cuts Risk of Cardiovascular Events in Patients With HIV
Significant reduction seen in incidence of major adverse cardiovascular event over median follow-up of 5.1 years.
.
Rapid ART Initiation Feasible During ED Admission May Improve Linkage to HIV Care
Researchers evaluated outcomes of a protocol to provide rapid antiretroviral therapy among patients testing HIV antigen/antibody reactive in the emergency department.
Twice-Annual Dispensing of PrEP Is Feasible and May Optimize HIV Care
Researchers compared rates of HIV testing and PrEP adherence with twice-annual vs quarterly PrEP dispensing.
CRISPR-Based Gene Therapy Candidate Fast Tracked for HIV Treatment
A phase 1/2 trial is evaluating the gene therapy in adult patients with HIV-1 who are on stable ART.
Hypertension and Blood Pressure Not Impacted by Dolutegravir in HIV
A study was conducted to determine if switching from protease inhibitors to dolutegravir can decrease hypertension risk in patients with HIV infection.
Does HIV PrEP Use Increase the Risk for Other Sexually Transmitted Infections?
Since the introduction of HIV PrEP in the MSM population, the incidence of other STIs has increased likely because of changes in sexual behaviors and condom use.
Breastfeeding Uncommon Among HIV-Positive Women in North America
Researchers assessed breastfeeding practices among HIV-positive women in North America.
Neurocognitive Deficits Observed in HIV Despite Long-Term Antiretroviral Therapy
Researchers compared neurocognitive function among patients with vs without HIV infection.
Meningococcal Disease Cases Up in Persons With HIV in 2022
Twenty-nine cases seen in 2022, based on preliminary data, accounting for 9.8% of all meningococcal disease cases.
Dolutegravir-Based ART Recommended in Pregnancy, Postpartum Period
Researchers assessed primary safety and virologic efficacy outcomes of 3 commonly used antiretroviral therapy regimens during pregnancy.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in HIV/AIDS Information Center
Loading... 
Loading...